Farmakogenetik og skræddersyet medicinsk behandling

Finn Cilius Nielsen; Niels Borregaard

Farmakogenetik og skræddersyet medicinsk behandling

Translated title of the contribution: Pharmacogenetics and tailored drug therapy

Finn Cilius Nielsen, Niels Borregaard

1 Citation (Scopus)

Abstract

Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology.

Translated title of the contribution	Pharmacogenetics and tailored drug therapy
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	171
Issue number	10
Pages (from-to)	790-4
Number of pages	5
ISSN	0041-5782
Publication status	Published - 2 Mar 2009
Externally published	Yes

Cite this

@article{be7ae2b9c54940248b01ad1143e3294f,

title = "Farmakogenetik og skr{\ae}ddersyet medicinsk behandling",

abstract = "Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology.",

keywords = "Antibodies, Monoclonal/therapeutic use, Antineoplastic Agents/therapeutic use, Benzamides, Humans, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy, Lung Neoplasms/drug therapy, Pharmacogenetics, Piperazines/therapeutic use, Protein Kinase Inhibitors/therapeutic use, Pyrimidines/therapeutic use",

author = "Nielsen, \{Finn Cilius\} and Niels Borregaard",

year = "2009",

month = mar,

day = "2",

language = "Dansk",

volume = "171",

pages = "790--4",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "10",

}

TY - JOUR

T1 - Farmakogenetik og skræddersyet medicinsk behandling

AU - Nielsen, Finn Cilius

AU - Borregaard, Niels

PY - 2009/3/2

Y1 - 2009/3/2

N2 - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology.

AB - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology.

KW - Antibodies, Monoclonal/therapeutic use

KW - Antineoplastic Agents/therapeutic use

KW - Benzamides

KW - Humans

KW - Imatinib Mesylate

KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy

KW - Lung Neoplasms/drug therapy

KW - Pharmacogenetics

KW - Piperazines/therapeutic use

KW - Protein Kinase Inhibitors/therapeutic use

KW - Pyrimidines/therapeutic use

UR - https://www.scopus.com/pages/publications/62249114964

M3 - Tidsskriftartikel

C2 - 19265602

SN - 0041-5782

VL - 171

SP - 790

EP - 794

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 10

ER -

Farmakogenetik og skræddersyet medicinsk behandling

Abstract

Other files and links

Fingerprint

Cite this